Sarah Cannon Research Institute
Sara Windham, M.S., has extensive experience in clinical research and project management, currently serving as a Research Monitor Associate and former Senior Clinical Project Associate at Sarah Cannon since October 2018. Additionally, Windham has worked as a Clinical Project Associate at Sarah Cannon Research Institute since August 2017. Prior experience includes roles as a Sales Associate at TJ Maxx, Graduate Assistant at Lipscomb University, and Student Admissions Recruiter at the same institution. Early career experience includes working as a Scribe for PhysAssist Scribes, Inc. Windham holds a Master’s degree in Biomolecular Science and a Bachelor’s degree in Molecular Biology from Lipscomb University, as well as an Associate’s degree in Biology from Walters State Community College.
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.